Norepinephrine Transporters: Targets for ADHD

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$301,412.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43HD046194-01
Agency Tracking Number:
HD046194
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
MOLECULAR INSIGHT PHARMACEUTICALS, INC.
MOLECULAR INSIGHT PHARMACEUTICALS, INC., 160 2ND ST, CAMBRIDGE, MA, 02142
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 FRANK Tarazi
 (617) 855-3176
 FTARAZI@HMS.HARVARD.EDU
Business Contact
Phone: (617) 492-5554
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Attention-deficit hyperactivity disorder (ADHD) is a complex developmental behavioral and cognitive disorder characterized by hyperactivity, inattention and impulsivity. The most widely prescribed pharmacological t

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government